209 related articles for article (PubMed ID: 30578328)
21. Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
Messer AE; Bayliss CR; El-Mezgueldi M; Redwood CS; Ward DG; Leung MC; Papadaki M; Dos Remedios C; Marston SB
Arch Biochem Biophys; 2016 Jul; 601():113-20. PubMed ID: 27036851
[TBL] [Abstract][Full Text] [Related]
22. Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
Schuldt M; Pei J; Harakalova M; Dorsch LM; Schlossarek S; Mokry M; Knol JC; Pham TV; Schelfhorst T; Piersma SR; Dos Remedios C; Dalinghaus M; Michels M; Asselbergs FW; Moutin MJ; Carrier L; Jimenez CR; van der Velden J; Kuster DWD
Circ Heart Fail; 2021 Jan; 14(1):e007022. PubMed ID: 33430602
[TBL] [Abstract][Full Text] [Related]
23. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins.
Rust EM; Albayya FP; Metzger JM
J Clin Invest; 1999 May; 103(10):1459-67. PubMed ID: 10330428
[TBL] [Abstract][Full Text] [Related]
24. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
[TBL] [Abstract][Full Text] [Related]
25. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
[TBL] [Abstract][Full Text] [Related]
26. Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human
Pioner JM; Vitale G; Steczina S; Langione M; Margara F; Santini L; Giardini F; Lazzeri E; Piroddi N; Scellini B; Palandri C; Schuldt M; Spinelli V; Girolami F; Mazzarotto F; van der Velden J; Cerbai E; Tesi C; Olivotto I; Bueno-Orovio A; Sacconi L; Coppini R; Ferrantini C; Regnier M; Poggesi C
Circ Res; 2023 Mar; 132(5):628-644. PubMed ID: 36744470
[TBL] [Abstract][Full Text] [Related]
27. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
[TBL] [Abstract][Full Text] [Related]
28. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
Parvatiyar MS; Landstrom AP; Figueiredo-Freitas C; Potter JD; Ackerman MJ; Pinto JR
J Biol Chem; 2012 Sep; 287(38):31845-55. PubMed ID: 22815480
[TBL] [Abstract][Full Text] [Related]
29. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
[TBL] [Abstract][Full Text] [Related]
30. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
31. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
[TBL] [Abstract][Full Text] [Related]
32. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca
Halas M; Langa P; Warren CM; Goldspink PH; Wolska BM; Solaro RJ
Mol Pharmacol; 2022 May; 101(5):286-299. PubMed ID: 35236770
[TBL] [Abstract][Full Text] [Related]
33. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
[TBL] [Abstract][Full Text] [Related]
34. The effect of variable troponin C mutation thin filament incorporation on cardiac muscle twitch contractions.
Mijailovich SM; Prodanovic M; Poggesi C; Powers JD; Davis J; Geeves MA; Regnier M
J Mol Cell Cardiol; 2021 Jun; 155():112-124. PubMed ID: 33636222
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.
Crilley JG; Boehm EA; Blair E; Rajagopalan B; Blamire AM; Styles P; McKenna WJ; Ostman-Smith I; Clarke K; Watkins H
J Am Coll Cardiol; 2003 May; 41(10):1776-82. PubMed ID: 12767664
[TBL] [Abstract][Full Text] [Related]
36. Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish.
Becker JR; Deo RC; Werdich AA; Panàkovà D; Coy S; MacRae CA
Dis Model Mech; 2011 May; 4(3):400-10. PubMed ID: 21245263
[TBL] [Abstract][Full Text] [Related]
37. Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.
Zile MA; Trayanova NA
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):418-428. PubMed ID: 28648627
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
[TBL] [Abstract][Full Text] [Related]
39. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
[TBL] [Abstract][Full Text] [Related]
40. Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium.
Piroddi N; Belus A; Scellini B; Tesi C; Giunti G; Cerbai E; Mugelli A; Poggesi C
Pflugers Arch; 2007 Apr; 454(1):63-73. PubMed ID: 17123098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
